Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | CBB-1007 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.7 |
mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | foretinib | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | 0.031 | 0.7 |
mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | 0.057 | 0.7 |
mRNA | XL765 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | OSI-027 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |